Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Synthomer (SYNT) Share News

Synthomer annual loss widens but on-track for longer-term growth

12th Mar 2024 10:58

(Alliance News) - Synthomer PLC on Tuesday said is loss widened in 2023 as revenue dropped, but said it has been taking "decisive actions" for longer term growth. Read More

UK earnings, trading statements calendar - next 7 days

5th Mar 2024 16:06

Read More

TRADING UPDATES: Synthomer predicts revenue decline amid challenges

30th Jan 2024 12:27

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

UK earnings, trading statements calendar - next 7 days

23rd Jan 2024 14:32

Read More

SMALL-CAP WINNERS & LOSERS: Trifast's annual performance to fall short

22nd Jan 2024 09:25

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday. Read More

LONDON BROKER RATINGS: Citi says 'buy' Segro; Barclays cuts Sage

22nd Jan 2024 09:10

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Tuesday: Read More

Grafton appoints former Vistry chair Ian Tyler as chair designate

17th Jan 2024 12:25

(Alliance News) - Grafton Group PLC said it appointed Ian Tyler, the former chair of Vistry Group PLC, as chair designate from the start of March. Read More

SMALL-CAP WINNERS & LOSERS: 888 revenue drops; Gulf Marine ups outlook

17th Jan 2024 09:59

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Wednesday. Read More

LONDON BROKER RATINGS: UBS cuts Shell, Admiral and M&G to 'neutral'

17th Jan 2024 09:10

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning: Read More

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

16th Jan 2024 09:14

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning: Read More

SMALL-CAP WINNERS & LOSERS: Ceres Power drops on RBC downgrade

12th Jan 2024 09:42

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday. Read More

LONDON BROKER RATINGS: Goldman likes Glencore; BofA likes easyJet

12th Jan 2024 09:14

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday: Read More

Berenberg "optimistic" on Synthomer despite high debt

12th Jan 2024 08:16

(Alliance News) - Synthomer PLC's chunky leverage has not put investors "at ease", though German bank Berenberg said that while debt is high, the firm's liquidity is too. Read More

UK earnings, trading statements calendar

9th Jan 2024 16:35

Read More

LONDON BROKER RATINGS: Shore cuts Sage; Barclays raises NatWest

17th Nov 2023 09:55

(Alliance News) - The following London-listed shares received analyst recommendations on Friday and Thursday. Read More

TRADING UPDATES: Synthomer trading consistent with expectations

15th Nov 2023 18:10

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

UK earnings, trading statements calendar - next 7 days

8th Nov 2023 15:46

Read More

SMALL-CAP WINNERS & LOSERS: Tirupati rises on Chinese export curbs

23rd Oct 2023 09:47

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday. Read More

IN BRIEF: Synthomer completes GBP276 million raise with rump placing

13th Oct 2023 11:48

Synthomer PLC - Harlow, Essex-based speciality chemical products maker - Synthomer's investment banks place the remain shares from its 6-for-1 rights issue, a total of 10.3 million shares, 7.4% of the overall rights issue. The share are placed at 200 pence each, meaning the rump sale is worth GBP20.6 million gross. In total, the rights issue raises GBP276 million. The rights price is 197p per share so the increment in price after expenses will be returned to shareholders who didn't take up their rights. The money raised for the company will be used to reduce debt and "provide stronger foundations to focus on delivering its speciality solutions strategy". The rights issue is accompanied by a 20-into-1 share consolidation, completed last month. Read More

SMALL-CAP WINNERS & LOSERS: Chrysalis rises on proposed buybacks

13th Oct 2023 10:08

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday. Read More

FTSE 100 Latest
Value8,786.81
Change-36.39